CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Lipocine - LPCN CFD

    2.36
    2.92%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.06
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Key Stats
    Prev. Close* 2.4
    Open* 2.37
    1-Year Change* 464.29%
    Day's Range* 2.33 - 2.45
    52 wk Range 3.30-14.28
    Average Volume (10 days) 10.37K
    Average Volume (3 months) 552.79K
    Market Cap 26.24M
    P/E Ratio -100.00K
    Shares Outstanding 88.51M
    Revenue 554.99K
    EPS -2.13
    Dividend (Yield %) N/A
    Beta 0.96
    Next Earnings Date Aug 7, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Nov 29, 2023 2.40 0.01 0.42% 2.39 2.49 2.38
    Nov 28, 2023 2.36 0.00 0.00% 2.36 2.38 2.33
    Nov 27, 2023 2.38 0.00 0.00% 2.38 2.50 2.36
    Nov 24, 2023 2.46 0.01 0.41% 2.45 2.49 2.45
    Nov 22, 2023 2.38 -0.06 -2.46% 2.44 2.45 2.35
    Nov 21, 2023 2.48 0.02 0.81% 2.46 2.58 2.43
    Nov 20, 2023 2.62 -0.01 -0.38% 2.63 2.68 2.59
    Nov 17, 2023 2.69 -0.03 -1.10% 2.72 2.72 2.67
    Nov 16, 2023 2.70 0.00 0.00% 2.70 2.74 2.64
    Nov 15, 2023 2.61 0.05 1.95% 2.56 2.68 2.56
    Nov 14, 2023 2.63 -0.03 -1.13% 2.66 2.82 2.63
    Nov 13, 2023 2.74 0.27 10.93% 2.47 3.05 2.40
    Nov 10, 2023 2.48 0.16 6.90% 2.32 2.48 2.32
    Nov 9, 2023 2.34 -0.11 -4.49% 2.45 2.49 2.34
    Nov 8, 2023 2.38 0.00 0.00% 2.38 2.50 2.37
    Nov 7, 2023 2.50 -0.01 -0.40% 2.51 2.60 2.50
    Nov 6, 2023 2.58 -0.03 -1.15% 2.61 2.65 2.56
    Nov 3, 2023 2.55 -0.02 -0.78% 2.57 2.64 2.50
    Nov 2, 2023 2.51 0.00 0.00% 2.51 2.58 2.46
    Nov 1, 2023 2.44 -0.06 -2.40% 2.50 2.53 2.36

    Lipocine Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 0.5 16.1408 0 0.16499 0.42803
    Total Operating Expense 12.3694 16.9953 17.7615 13.0653 11.7538
    Selling/General/Admin. Expenses, Total 4.06249 5.32978 8.2478 5.59707 5.28914
    Research & Development 8.55689 7.66556 9.74847 7.46821 6.46471
    Unusual Expense (Income) -0.25 4 -0.2348 0
    Operating Income -11.8694 -0.8545 -17.7615 -12.9003 -11.3258
    Other, Net 0.56594 0.35589 -2.89219 0.2364 -0.3335
    Net Income Before Taxes -10.758 -0.6342 -20.9646 -13.0071 -11.6593
    Net Income After Taxes -10.7586 -0.6344 -20.9648 -13.0073 -11.66
    Net Income Before Extra. Items -10.7586 -0.6344 -20.9648 -13.0073 -11.66
    Net Income -10.7586 -0.6344 -20.9648 -13.0073 -11.66
    Income Available to Common Excl. Extra. Items -10.7586 -0.6344 -20.9648 -13.0073 -11.66
    Income Available to Common Incl. Extra. Items -10.7586 -0.6344 -20.9648 -13.0073 -11.66
    Diluted Net Income -10.7586 -0.6344 -20.9648 -13.0073 -11.66
    Diluted Weighted Average Shares 5.22768 5.11349 3.27557 1.5224 1.25594
    Diluted EPS Excluding Extraordinary Items -2.05801 -0.12406 -6.40035 -8.544 -9.28387
    Diluted Normalized EPS -2.0891 0.38439 -6.44695 -8.544 -9.28387
    Total Extraordinary Items
    Revenue 0.5 16.1408 0 0.16499 0.42803
    Interest Income (Expense), Net Non-Operating 0.54548 -0.13559 -0.31097 -0.34325
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total revenue 0.05499 0 0 0.5 0
    Revenue 0.05499 0 0 0.5
    Total Operating Expense 4.39362 2.56083 2.89937 3.77753 3.13164
    Selling/General/Admin. Expenses, Total 1.28731 0.89034 0.79894 1.12952 1.24369
    Research & Development 3.10631 1.67049 2.10043 2.89801 1.88795
    Operating Income -4.33863 -2.56083 -2.89937 -3.27753 -3.13164
    Interest Income (Expense), Net Non-Operating 0.37047 0.29716 0.16397 0.06231 0.02205
    Other, Net 0.09813 0.03424 0.32624 0.58345 -0.37799
    Net Income Before Taxes -3.87003 -2.22943 -2.40917 -2.63178 -3.48758
    Net Income After Taxes -3.87023 -2.22991 -2.40917 -2.63178 -3.48778
    Net Income Before Extra. Items -3.87023 -2.22991 -2.40917 -2.63178 -3.48778
    Net Income -3.87023 -2.22991 -2.40917 -2.63178 -3.48778
    Income Available to Common Excl. Extra. Items -3.87032 -2.22991 -2.40917 -2.63178 -3.48778
    Income Available to Common Incl. Extra. Items -3.87032 -2.22991 -2.40917 -2.63178 -3.48778
    Diluted Net Income -3.87032 -2.22991 -2.40917 -2.63178 -3.48778
    Diluted Weighted Average Shares 5.20652 5.30475 5.20595 5.20552 5.19437
    Diluted EPS Excluding Extraordinary Items -0.74336 -0.42036 -0.46277 -0.50557 -0.67145
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.74336 -0.42036 -0.46277 -0.5536 -0.67145
    Unusual Expense (Income) 0 0 -0.25
    Total Adjustments to Net Income -0.00009
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 34.1351 46.3797 25.329 19.631 20.8092
    Cash and Short Term Investments 32.5299 44.618 19.6674 14.0686 15.2506
    Cash & Equivalents 3.1485 2.95055 19.2174 9.72852 8.07754
    Short Term Investments 29.3814 41.6674 0.44999 4.34004 7.17304
    Total Receivables, Net 0.08043 0.24725 0.00039 0.01652 0.03851
    Accounts Receivable - Trade, Net 0.08043 0.24725 0.00039 0.01652 0.03851
    Prepaid Expenses 0.94532 1.51447 0.66126 0.54589 0.52011
    Total Assets 37.5429 52.4824 25.3528 19.6583 20.8519
    Property/Plant/Equipment, Total - Net 0.13159 0.00721 0 0.00355 0.019
    Property/Plant/Equipment, Total - Gross 1.28512 1.15129 1.1437 1.1437 1.1437
    Accumulated Depreciation, Total -1.15353 -1.14408 -1.1437 -1.14014 -1.1247
    Long Term Investments 0 2.0218
    Other Long Term Assets, Total 0.02375 0.02375 0.02375 0.02375 0.02375
    Total Current Liabilities 1.67813 5.61663 6.58373 4.96488 4.49175
    Accounts Payable 0.60039 1.28934 1.59722 1.18224 0.67128
    Accrued Expenses 1.07774 2.01646 1.65318 0.4493 0.48714
    Notes Payable/Short Term Debt 0 0 0 0 0
    Total Liabilities 1.90798 6.91242 10.0109 13.3705 11.4183
    Total Long Term Debt 0 0 2.25708 3.81441 6.92653
    Total Equity 35.6349 45.57 15.3419 6.2878 9.43367
    Preferred Stock - Non Redeemable, Net 0 0 0 0 0
    Common Stock 0.00885 0.00883 0.00701 0.00377 0.00217
    Additional Paid-In Capital 219.112 218.286 187.408 157.392 147.533
    Retained Earnings (Accumulated Deficit) -183.425 -172.666 -172.032 -151.067 -138.06
    Treasury Stock - Common -0.04071 -0.04071 -0.04071 -0.04071 -0.04071
    Other Equity, Total -0.02032 -0.01802 0 -0.00004 -0.00096
    Total Liabilities & Shareholders’ Equity 37.5429 52.4824 25.3528 19.6583 20.8519
    Total Common Shares Outstanding 5.2062 5.19326 4.11953 2.21454 1.27825
    Other Current Liabilities, Total 0
    Other Current Assets, Total 0.57943 0 5 5 5
    Current Port. of LT Debt/Capital Leases 0 2.31083 3.33333 3.33333 3.33333
    Long Term Debt 0 2.25708 3.81441 6.92653
    Other Liabilities, Total 0.22986 1.2958 1.17005 4.5912
    Note Receivable - Long Term 3.2525 4.05
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 30.6148 34.1351 36.1105 38.0796 43.4976
    Cash and Short Term Investments 28.8696 32.5299 34.2558 37.3957 41.9995
    Cash & Equivalents 4.76918 3.1485 2.39696 4.98119 5.73323
    Short Term Investments 24.1004 29.3814 31.8588 32.4145 36.2663
    Total Receivables, Net 0.03906 0.08043 0.04077 0.08041 0.12009
    Accounts Receivable - Trade, Net 0.03906 0.08043 0.04077 0.08041 0.12009
    Prepaid Expenses 1.12673 0.94532 1.23454 0.60355 1.37793
    Other Current Assets, Total 0.57943 0.57943 0.57943
    Total Assets 34.0219 37.5429 39.4242 42.1934 47.6036
    Long Term Investments 0 0 0 0
    Other Long Term Assets, Total 0.02375 0.02375 0.02375 0.02375 0.02375
    Total Current Liabilities 1.9301 1.67813 1.51131 1.71331 3.51995
    Accounts Payable 0.79648 0.60039 0.63046 0.814 0.46989
    Accrued Expenses 1.13363 1.07774 0.88085 0.8993 1.5679
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0 0 0 1.48217
    Total Liabilities 2.06182 1.90798 1.77541 2.30364 5.19374
    Total Long Term Debt 0 0 0 0 0
    Long Term Debt
    Other Liabilities, Total 0.13172 0.22986 0.2641 0.59034 1.67379
    Total Equity 31.96 35.6349 37.6488 39.8898 42.4099
    Common Stock 0.00885 0.00885 0.00885 0.00885 0.00885
    Additional Paid-In Capital 219.284 219.112 218.953 218.792 218.663
    Retained Earnings (Accumulated Deficit) -187.295 -183.425 -181.195 -178.786 -176.154
    Treasury Stock - Common -0.04071 -0.04071 -0.04071 -0.04071 -0.04071
    Other Equity, Total 0.00324 -0.02032 -0.07694 -0.08491 -0.06742
    Total Liabilities & Shareholders’ Equity 34.0219 37.5429 39.4242 42.1934 47.6036
    Total Common Shares Outstanding 5.20652 5.2062 5.2062 5.20552 5.20551
    Preferred Stock - Non Redeemable, Net 0.00001 0 0 0 0
    Property/Plant/Equipment, Total - Net 0.13077 0.13159 0.03744 0.04001 0.03229
    Accumulated Depreciation, Total -1.15835 -1.15353 -1.14837
    Note Receivable - Long Term 3.2525 3.2525 3.2525 4.05 4.05
    Property/Plant/Equipment, Total - Gross 1.28912
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -10.7586 -0.6344 -20.9648 -13.0073 -11.66
    Cash From Operating Activities -11.9688 -4.4113 -15.3031 -11.6662 -12.0788
    Cash From Operating Activities 0.00945 0.00038 0.00355 0.01544 0.0186
    Non-Cash Items -0.29601 0.81738 4.13729 0.85634 1.55672
    Changes in Working Capital -0.92363 -4.59467 1.52088 0.46935 -1.99412
    Cash From Investing Activities 14.2937 -43.7804 3.8927 2.99823 11.2933
    Capital Expenditures -0.13383 -0.00759
    Other Investing Cash Flow Items, Total 14.4275 -43.7728 3.8927 2.99823 11.2933
    Cash From Financing Activities -2.12694 26.9249 20.8993 10.319 10.6523
    Issuance (Retirement) of Stock, Net 0.18972 30.2582 22.3324 13.6523 0.65233
    Net Change in Cash 0.19794 -21.2668 9.48886 1.65098 9.86679
    Cash Taxes Paid 0.0002 0.0002 0.0002 0.0007 0.0007
    Cash Interest Paid 0.02126 0.14954 0.27602 0.54554 0.53354
    Issuance (Retirement) of Debt, Net -2.31667 -3.33333 -1.43313 -3.33333 10
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -3.87023 -10.7586 -8.52872 -6.11956 -3.48778
    Cash From Operating Activities -3.92806 -11.9688 -10.1299 -6.93173 -3.8854
    Cash From Operating Activities 0.00482 0.00945 0.00688 0.0043 0.00172
    Non-Cash Items -0.17458 -0.29601 -0.26804 -0.05174 0.60497
    Cash Interest Paid 0 0.02126 0.02126 0.02126 0.01486
    Changes in Working Capital 0.11193 -0.92363 -1.34001 -0.76473 -1.00431
    Cash From Investing Activities 5.55476 14.2937 11.6974 11.0835 7.29543
    Other Investing Cash Flow Items, Total 5.55876 14.4275 11.7345 11.1206 7.32222
    Cash From Financing Activities -0.00602 -2.12694 -2.12104 -2.12109 -0.62735
    Issuance (Retirement) of Stock, Net 0 0.18972 0.19562 0.19558 0.20599
    Issuance (Retirement) of Debt, Net 0 -2.31667 -2.31667 -2.31667 -0.83333
    Net Change in Cash 1.62068 0.19794 -0.55359 2.03064 2.78268
    Cash Taxes Paid 0.00046 0.0002 0.0002 0.0002
    Capital Expenditures -0.004 -0.13383 -0.0371 -0.0371 -0.0268
    Financing Cash Flow Items -0.00602

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Lipocine Company profile

    Lipocine
    Industry: Bio Therapeutic Drugs

    675 S Arapeen Dr Ste 202
    SALT LAKE CITY
    UTAH 84108-1295
    US

    Income Statement

    • Annual
    • Quarterly

    News

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    Gold Rises as Traders price-in Fed Rate Cuts

    Gold prices have declined despite a drop in Treasury yields and a weaker US Dollar. We look at the key drivers and technical levels for the gold price.

    13:17, 20 November 2023

    People also watch

    Gold

    2,035.54 Price
    -0.440% 1D Chg, %
    Long position overnight fee -0.0196%
    Short position overnight fee 0.0114%
    Overnight fee time 22:00 (UTC)
    Spread 0.30

    Oil - Crude

    76.09 Price
    -2.010% 1D Chg, %
    Long position overnight fee -0.0165%
    Short position overnight fee -0.0054%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    US100

    15,851.60 Price
    -0.860% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    BTC/USD

    37,782.65 Price
    +0.030% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading